Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
91855917 | 9185591 | 7 | F | 20160720 | 20130325 | 20160725 | EXP | PHHY2013CA028258 | NOVARTIS | 0.00 | F | Y | 0.00000 | 20160725 | CN | CA | CA |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
91855917 | 9185591 | 1 | PS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 30 MG, QMO | 21008 | 30 | MG | SUSPENSION | /month | ||||||
91855917 | 9185591 | 2 | SS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 60 MG, QMO | 21008 | 60 | MG | SUSPENSION | /month | ||||||
91855917 | 9185591 | 3 | SS | AFINITOR | EVEROLIMUS | 1 | Oral | 10 MG, QD | 0 | 10 | MG | QD | |||||||
91855917 | 9185591 | 4 | C | FERROUS SULFATE. | FERROUS SULFATE | 1 | Unknown | 30 MG, QD | U | 0 | 30 | MG | QD | ||||||
91855917 | 9185591 | 5 | C | PANTOLOC//PANTOPRAZOLE SODIUM SESQUIHYDRATE | PANTOPRAZOLE SODIUM | 1 | Unknown | 40 MG, PRN | U | 0 | 40 | MG |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
91855917 | 9185591 | 1 | Pancreatic neuroendocrine tumour |
91855917 | 9185591 | 3 | Pancreatic neuroendocrine tumour |
91855917 | 9185591 | 4 | Product used for unknown indication |
91855917 | 9185591 | 5 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
91855917 | 9185591 | HO |
91855917 | 9185591 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
91855917 | 9185591 | Hepatic lesion | |
91855917 | 9185591 | Hypersensitivity | |
91855917 | 9185591 | Infection | |
91855917 | 9185591 | Malignant neoplasm progression | |
91855917 | 9185591 | Metastases to liver |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
91855917 | 9185591 | 1 | 20090422 | 0 | ||
91855917 | 9185591 | 3 | 20160407 | 0 |